Peripheral cannabinoid receptors exert a powerful inhibitory control over pain initiation, but the endocannabinoid signal that normally engages this intrinsic analgesic mechanism is unknown. To address this question, we developed a peripherally restricted inhibitor (URB937) of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degradation of the endocannabinoid anandamide. URB937 suppressed FAAH activity and increased anandamide levels outside the rodent CNS. Despite its inability to access brain and spinal cord, URB937 attenuated behavioral responses indicative of persistent pain in rodent models of peripheral nerve injury and inflammation and prevented noxious stimulus–evoked neuronal activation in spinal cord regions implicated in nociceptive processing. CB1 cannabinoid receptor blockade prevented these effects. These results suggest that anandamide-mediated signaling at peripheral CB1 receptors controls the access of pain-related inputs to the CNS. Brain-impenetrant FAAH inhibitors, which strengthen this gating mechanism, might offer a new approach to pain therapy.

Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism / Clapper, J. R.; G., Moreno Sanz; Russo, Roberto; A., Guijarro; F., Vacondio; A., Duranti; A., Tontini; S., Sanchini; Sciolino, R. M.; Spradley, J. M.; Hohmann, A. G.; Calignano, Antonio; M., Mor; G., Tarzia; D., Piomelli. - In: NATURE NEUROSCIENCE. - ISSN 1097-6256. - STAMPA. - 13:10(2010), pp. 1265-1270. [10.1038/nn.2632]

Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism

RUSSO, ROBERTO;CALIGNANO, ANTONIO;
2010

Abstract

Peripheral cannabinoid receptors exert a powerful inhibitory control over pain initiation, but the endocannabinoid signal that normally engages this intrinsic analgesic mechanism is unknown. To address this question, we developed a peripherally restricted inhibitor (URB937) of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degradation of the endocannabinoid anandamide. URB937 suppressed FAAH activity and increased anandamide levels outside the rodent CNS. Despite its inability to access brain and spinal cord, URB937 attenuated behavioral responses indicative of persistent pain in rodent models of peripheral nerve injury and inflammation and prevented noxious stimulus–evoked neuronal activation in spinal cord regions implicated in nociceptive processing. CB1 cannabinoid receptor blockade prevented these effects. These results suggest that anandamide-mediated signaling at peripheral CB1 receptors controls the access of pain-related inputs to the CNS. Brain-impenetrant FAAH inhibitors, which strengthen this gating mechanism, might offer a new approach to pain therapy.
2010
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism / Clapper, J. R.; G., Moreno Sanz; Russo, Roberto; A., Guijarro; F., Vacondio; A., Duranti; A., Tontini; S., Sanchini; Sciolino, R. M.; Spradley, J. M.; Hohmann, A. G.; Calignano, Antonio; M., Mor; G., Tarzia; D., Piomelli. - In: NATURE NEUROSCIENCE. - ISSN 1097-6256. - STAMPA. - 13:10(2010), pp. 1265-1270. [10.1038/nn.2632]
File in questo prodotto:
File Dimensione Formato  
anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Accesso privato/ristretto
Dimensione 711.72 kB
Formato Adobe PDF
711.72 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/374411
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 277
  • ???jsp.display-item.citation.isi??? 260
social impact